CLEAN : World conference meets on silent epidemic hepatitis

The video discusses hepatitis as a silent epidemic, highlighting the lack of symptoms and the long time it takes for them to appear. It addresses the challenges in diagnosing the disease, with a large number of people remaining undiagnosed. The video also explores the role of pharmaceutical companies in controlling drug patents, which limits access to affordable generics. Finally, it touches on the financial barriers that prevent many from accessing necessary treatments.

What is the significance of hepatitis being described as a silent epidemic?

What percentage of hepatitis cases are estimated to be undiagnosed?

Why is it challenging to diagnose hepatitis in many individuals?

What role do big pharmaceutical companies play in the availability of hepatitis treatments?

Discuss the financial challenges faced by individuals seeking treatment for hepatitis.